Skip to main content

A narrative review on yoga: a potential intervention for augmenting immunomodulation and mental health in COVID-19



The ongoing novel coronavirus disease 2019 (COVID-19) pandemic has a significant mortality rate of 3–5%. The principal causes of multiorgan failure and death are cytokine release syndrome and immune dysfunction. Stress, anxiety, and depression has been aggravated by the pandemic and its resultant restrictions in day-to-day life which may contribute to immune dysregulation. Thus, immunity strengthening and the prevention of cytokine release syndrome are important for preventing and minimizing mortality in COVID-19 patients. However, despite a few specific remedies that now exist for the SARS-CoV-2virus, the principal modes of prevention include vaccination, masking, and holistic healing methods, such as yoga. Currently, extensive research is being conducted to better understand the neuroendocrinoimmunological mechanisms by which yoga alleviates stress and inflammation. This review article explores the anti-inflammatory and immune-modulating potentials of yoga, along with its role in reducing risk for immune dysfunction and impaired mental health.


We conducted this narrative review from published literature in MEDLINE, EMBASE, COCHRANE databases. Screening was performed for titles and abstracts by two independent review authors; potentially eligible citations were retrieved for full-text review. References of included articles and articles of major non-indexed peer reviewed journals were searched for relevance by two independent review authors. A third review author checked the excluded records. All disagreements were resolved through discussion amongst review authors or through adjudication by a fourth review author. Abstracts, editorials, conference proceedings and clinical trial registrations were excluded.


Yoga is a nonpharmacological, cost-effective, and safe intervention associated with several health benefits. Originating in ancient India, this vast discipline consists of postures (asanas), breathing techniques (pranayama), meditation (dhyana/dharana), and relaxation. Studies have demonstrated yoga’s ability to bolster innate immunity and to inhibit cytokine release syndrome. As an intervention, yoga has been shown to improve mental health, as it alleviates anxiety, depression, and stress and enhances mindfulness, self-control, and self-regulation. Yoga has been correlated with numerous cardioprotective effects, which also may play a role in COVID-19 by preventing lung and cardiac injury.

Conclusion and relevance

This review paves the path for further research on yoga as a potential intervention for enhancing innate immunity and mental health and thus its role in prevention and adjunctive treatment in COVID-19.

Peer Review reports


Coronavirus disease (COVID-19) is a highly contagious viral disease that has affected 238,349,712 people worldwide as of October 9, 2021. Its outbreak was initially reported in 2019 in Wuhan, Hubei Province, China. Nearly 5 million deaths had been reported worldwide as of the first week of October 2021. Many countries are still “locked down” to prevent extensive spread of infection, whereas others have relaxed these measures; even so, social isolation measures are still generally recommended, at least to some extent. Many argue that easing social restrictions has contributed to spikes in the number of cases nationwide [1,2,3,4,5].

Given the limited treatment options and the emergence of multiple strains with variable susceptibility to vaccines, clinicians are searching for other interventions to aid in the prevention and treatment of COVID-19. In the context of integrative medicine, yoga is a mind-body discipline that promotes healthy living through various components, such as the practice of postures (asana), breathing techniques (pranayama), concentration (dharana), and meditation (dhyana) [2, 6]. A growing body of evidence suggests that yoga practice leads to better integrative management of a number of non-communicable diseases that share the same pathophysiology, including cardiovascular diseases, stroke, and diabetes mellitus type II. The underlying reasoning is that these diseases, like COVID-19, express rogue immunological aberration, resulting in many of their manifestations, which are often triggered or exacerbated by stress [2, 7]. A meta-analysis of ten randomized controlled trials including 431 individuals suggested that yoga programs improved exercise capacity (mean change 2.69, 95% confidence interval 1.39- 3.99) and health related quality of life (mean change 1.24, 95% confidence interval − 0.37- 2.85) among patients with chronic ailments namely heart disease, chronic obstructive pulmonary disease and stroke when compared with normal care [8]. Consistent practice of yoga strengthens innate and adaptive immunity and helps to enhance physiological functions, such as respiration, digestion, circulation, and hormone production [2, 9,10,11].

In this review article, we discuss inflammatory, infectious, and psychosocial aspects of COVID-19 and explore the anti-inflammatory and immune-modulating potentials of yoga, along with its role in reducing risk factors for immune dysfunction and impaired mental health. We propose yoga as an intervention for expediting recovery in patients with COVID-19 and for enhancing innate immunity and mental health to bolster resistance to the virus [2].


We conducted this narrative review from published literature in MEDLINE, EMBASE, and COCHRANE databases. Articles were retrieved from database searches using keywords related to complementary therapy, COVID-19, immunomodulation, psychological stress, and yoga. Observational and experimental studies and discussing the role of yoga in anxiety, immunomodulation, and COVID-19 were considered relevant for this narrative review. Screening was performed for titles and abstracts by two independent review authors; potentially eligible citations were retrieved for full-text review. References of included articles and articles of major non-indexed peer reviewed journals were searched for relevance by two independent review authors. A third review author checked the excluded records. All disagreements were resolved through discussion amongst review authors or through adjudication by a fourth review author. Abstracts, editorials, conference proceedings and clinical trial registrations were excluded. Only articles in English language were included.

SARS-COV-2 infection

SARS-CoV-2, the coronavirus that causes COVID-19, is an acute infectious agent that enters the body through the respiratory system. Droplet transmission is understood to be the primary mode of transmission. Mounting evidence also suggests airborne transmission, although the World Health Organization has yet to confirm this. A person can become infected when his or her mucus membrane (within the nose, eyes, or mouth) comes into contact with the respiratory secretions of an actively infected person discharging virus particles. Having entered the body, the SARS-CoV-2 virus uses its S-spike to bind angiotensin-converting enzyme (ACE)-2 receptors as an entry point into the cell. The ACE2 receptor is expressed primarily in both type I and type II pneumocytes but also in other types of cells, including endothelial cells. Thus, it plays a vital role in vascular integrity and hemodynamic regulation [12,13,14].

Evidence indicates that cardiac involvement is ubiquitous in patients with COVID-19, particularly in hospitalized patients [14]. Patients with cardiac risk factors or established cardiovascular disease have heightened vulnerability, along with worse mortality and morbidity profiles. In various studies, nearly 30% of afflicted patients had hypertension and 15% had preexisting cardiovascular disease [15, 16].

Role of immunity in COVID-19

The human immune system comprises multiple organs, such as the spleen, thymus, lymph nodes, tonsils, and bones. Immune cells and their products destroy the intruding infective organisms and neutralize them. The immune system includes both innate immunity and adaptive immunity. Innate immunity is the rapid-acting first line of defense that effectively inhibits infective agents from entering the body. However, if this line of defense fails, the immune system activates adaptive immunity, which is important to control most viral infections. The emerging picture reveals that CD4+ T cells, CD8+ T cells and neutralizing antibodies has important role in COVID-19 and thus its prevention and management [17].

Innate immunity is garnered to restrict infections by novel pathogens, such as SARS-CoV-2. This elaborate immunological cascade appropriately arrests the disease and helps to initiate the repair mechanism, thus ensuring satisfactory resolution of the infection and generating targeted resistance to defend the body against reinfection by the same organism [18]. The adaptive immune system involves T lymphocytes, B lymphocytes, and pathogen-specific antibodies in addition to the proinflammatory cytokines and chemokines that help to eliminate the pathogen [19]. Although these processes are very potent and effective, they can render bystander damage to the body’s own cells and organs.

Infection with COVID-19 presents with three different clinical scenarios: (1) asymptomatic carriers who have adequately functioning innate immunity; (2) symptomatic carriers with mild symptoms who achieve spontaneous recovery as their innate immunity detects infection and restricts it, while generating adaptive immunity that optimally gets rid of the virus; and (3) patients who develop moderate to severe illness and either recover or die from the infection [20]. In this third category of patients, the body’s immune system, in both its innate and adaptive expressions, is activated. In those who die, the immune system is overwhelmed, leading to cytokine release syndrome (CRS), a massive, cascading release of cytokines that initiates widespread destruction and multiorgan failure, ultimately leading to death [13]. In essence, the virus does not directly kill but instead initiates an immunological reaction that is morbid and occasionally fatal (Fig. 1). It is therefore unfortunate that the resources harnessed by the body to kill the virus largely outweigh the appropriate levels needed and instead produce tissue destruction, organ failure, and eventually death. Interleukin (IL)-6 is the primary candidate cytokine suspected of perpetrating this fatal reaction [14, 15]. This knowledge has spawned initiatives to block IL-6 using receptor inhibitors, including biologics like tocilizumab, which are undergoing trials in moderately to severely ill patients with COVID-19 [19].

Fig. 1
figure 1

Pathological changes in lungs in early and severe stages of COVID-19 [From “SARS-CoV-2 and viral sepsis: observations and hypotheses” by Li H, Liu L, Zhang D, et al.; accessed 10 April 2021] [Permission for re-use granted by Elsevier COVID-19 resource center guidelines] [21]

An optimal innate immune response may thus play a vital role in the prevention and early disposal of most COVID-19 infections. A response of this nature is believed to occur in 80% or more of those infected, who either are asymptomatic or develop mild symptoms that defervesce and culminate in an uneventful recovery. The precise cause of immune dysfunction and CRS led by the overproduction of IL-6 is unknown. Nonetheless, considerable evidence points to the fact that the severity of the disease is based on the immune response to the virus, among other factors [22].

Pandemics, immunity, and mental health

Remdesivir, the antiviral agent effective against COVID-19, only shortens the illness timetable by around 33% [23]. The antiviral treatments recently approved by the FDA would lead to resistance if randomly used. Moreover, their efficacy is not absolute and is only effective if started early in the course of the infection. These limitations render preventive measures—including vaccination, hygiene, social distancing, and personal protective equipment—to be the primary means of managing the COVID-19 pandemic. Social distancing through partial or complete lockdowns often leads to psychological issues such as anxiety, depression, and panic attacks—all of which are known to downregulate the immune system [2, 24]. Associated economic downturns, featuring job losses and financial hardships, have accentuated mental health issues during the pandemic [25]; suicides, opioid overdoses, and domestic violence also have increased. When vulnerable persons such as children, pregnant women, or elderly relatives are part of the household, stress and anxiety levels appear to worsen, given the higher disease severity and mortality rates in these groups. The conglomeration of stress states is associated with downregulation of immunity and, consequently, with worsened disease manifestations.


Both chronic and sub-acute stress have a significant negative impact on the immune system [26]: on the one hand, the ability to cope with stress helps preserve immune function; on the other hand, individuals with higher stress levels and poor coping mechanisms have subpar immunity. Lower resilience to stress is associated with poor antibody response and decreased natural-killer cell activity [27, 28].

Stress affects immune function by increasing glucocorticoid and catecholamine secretion. Stress also induces chronic sympathetic overdrive as it simultaneously attenuates the parasympathetic system [29]. Escalated sympathetic drive with its attendant hormonal milieu (including cortisol excess and a robust catecholaminergic drive) attenuates the efficacy of the immune system [30]. The aberrant pathophysiology at play under such conditions is increased inflammation and decreased protection against invading microorganisms [30]. Increased glucocorticoid levels significantly affect the immune function by dysregulating cytokine production, affecting natural-killer cell activity and reducing immunoglobulin A (IgA) production [30]. Elevated cortisol potentiates glucose intolerance and diabetes and thus further increases the risk for infection [31]. Moreover, evidence suggests that people who have stressful life events have greater risk for respiratory infections [32]. The higher stress levels associated with extended lockdowns and the concomitant fear, anxiety, and depression lead to weakened immunity, opening the floodgates of infection [33].

The paradoxical response of augmented inflammation that is elicited during stress despite increased corticosteroid levels in the blood is not clearly delineated. After all, chronic stressors should ameliorate the symptoms of inflammation-related diseases, but this conclusion is at odds with the excess morbidity and mortality documented in chronically stressed individuals. Miller and colleagues [34] have put forth an alternative hypothesis that posits the development of macrophage resistance to cortisol negative feedback under conditions of chronic stress, due to compensatory downregulation at the immune cell (glucocorticoid) receptor. Early life stress can give rise to blunted cortisol negative feedback of the innate inflammatory response [35]. This may set the stage for the stress-related chronic inflammation thought to lower the threshold for stress-related noncommunicable disease [36]. However, the research establishing cell surface receptor compensatory changes under conditions of stress has thus far been unimpressive. Further research is needed to discern the probable mechanism for this phenomenon.


During lockdowns, social isolation and lack of physical activity are two prominent risk factors for depression. Depression increases the risk ofCOVID-19 infection significantly. There was increased mortality and hospitalization rates among COVID-19 infected patients having recently diagnosed depression [37].

Compared with nondepressed cohorts, individuals with recently diagnosed depression were found to have a significantly higher risk for COVID-19 infection (Adjusted Odds Ratio 7.64, 95% confidence interval 7.45- 7.83) [35, 36]. Depression is correlated with alteration in immune markers, including decreases in mitogen proliferation, natural-killer cell activity, and the types and respective quantities of antibodies produced [38]. Depression also dysregulates the neuroendocrine system [39] and consequently increases inflammation, altering the immune system’s effectiveness while simultaneously increasing bystander damage [40]. Patients with depression have disrupted T-cell function and elevated levels of cytokines, such as tumor necrosis factor (TNF)-α, IL-1, and IL-6 [40].


Pandemics are associated with heightened anxiety, on both the collective and individual levels. The highly contagious nature of COVID-19 and the lack of treatment options add to the increased threat to survival and may trigger or aggravate existing anxiety and panic disorders.

Anxiety contributes to significant dysfunction in immune function by dysregulating the hypothalamic-pituitary-adrenal (HPA) axis [41, 42]. In a study of 42 patients with panic disorder and 42 healthy individuals, Koh and Lee observed significantly lower IL-2 production and lymphocyte proliferation levels in patients with anxiety disorder than in those without [43]. Complex changes in the inflammation milieu related to aberrant cytokines, particularly IL-1β, IL-6, TNF-α, and interferon (IFN)-γ, have been documented in anxiety-based disorders [44]. Furthermore, patients with anxiety disorder exhibit lower CD4+ cell counts, compared with healthy controls. Studies have also documented the elevation of suppressor CD8+ cells in these conditions, along with a potentiated cytokine response [45]. This abnormal response of the body’s immunological system in anxiety and depression may contribute to heightened infection and mishandling of severe infection, leading to a magnified, self-damaging cytokine response [46].

Yoga and immunity

Yoga is noted to have a positive impact on the immune system [47,48,49] and inflammation pathways (Table 1). It reduces inflammation and increases the number and activity of natural-killer cells [50,51,52], thus enhancing cell-mediated cytotoxicity of invading infective agents. Evidence shows that yoga practice is associated with improvement in CD3+ and CD4+ cell counts, salivary cortisol levels, and IgA [53], a dominant player in innate immunity that is present on body linings, such as those of the lungs and the gastrointestinal tract [54]. With yogic intervention, IgA levels increase at the exposed lung border, where type II pneumocytes are prevalent. Additionally, cortisol, which dampens the body’s ability to fight infection, is decreased by practicing yoga.

Table 1 Studies on Yoga and Immunity

Yoga has been found to be effective in immunocompromised conditions such as HIV. It helps to improve CD4+ count and anxiety, depression, and stress among patients with HIV [47, 56]. It has found to be equally effective in improving CD56+ cell count, anxiety, and depression in chronic disorders such as cancer [51].

The cytokine storm unleashed by the body’s unregulated response to SARS-CoV-2 induces multiorgan damage, resulting in high morbidity and mortality. Myocarditis with severe refractory acute heart failure has been noted [57]. As myocarditis is a clear signal for cytokine-mediated damage, direct damage by the SARS-CoV-2 virus cannot be discounted, as both the heart and vascular endothelium express the ACE2 receptors that are entry gates for COVID-19 [13]. Cytokine profiles in patients diagnosed with COVID-19 showed marked elevation of T-helper lymphocyte type 1, IFN-γ, and inflammatory cytokines IL-1β, IL-6, and IL-12 for at least 2 weeks after disease onset [58]. Among these, IL-6 is a predictor of mortality in COVID-19 patients, which may explain why primary evidence suggests that IL-6 inhibitors have shown promise as treatments [2, 59].

Nagarathna et al. have documented the downregulation of pro-inflammatory markers by yoga in their review article, hence supporting the utility of yoga as a complementary intervention for subjects at risk or already infected by SARS-CoV-2 virus [60]. Evidence indicates that yoga practice helps to reduce inflammation by downregulating a vast array of initiators and modulators that perpetuate chronic inflammation, including IL-6, TNF-α, and IL-1β [59, 60].

Multiple randomized controlled trials have documented a significant reduction in IL-6 levels in yoga groups as compared with controls [61]. In one study, researchers observed a significant reduction in IL-6 at the 3-month follow-up in breast cancer patients who practiced yoga, compared with a non-yoga control group [62]. Moreover, increasing the amount of yoga practice led to a more pronounced decrease in IL-6, pointing towards a potential dose-response effect. Another randomized trial showed significantly reduced IL-6 secretion after yoga practice in healthy individuals and significantly reduced secretion of IL-6 when cultured blood was challenged with a toll-like receptor agonist [62]. Multiple studies have substantiated the beneficial effect of yoga on inflammation and how it leads to CRS reduction, if not inhibition (Table 2).

Table 2 Studies on Yoga and Inflammation

Yoga during stressful events

Various clinical trials have suggested a significant role for yoga in reducing depression and its associated variables (Table 3). In one study, 16 distressed women received 3 months of Iyengar yoga intervention, and a group of 8 women served as a control. After 3 months, women in the yoga group showed a significant decrease in perceived stress, depression, and anxiety and in salivary cortisol; well-being improved significantly in the yoga group, compared with controls [65].

Table 3 Studies on Yoga and Stress, Anxiety and Depression

Yoga practice helps adherents to develop a positive attitude during stress and to enhance self-awareness and coping ability (Fig. 2). Yoga (asana, pranayama, and meditation) improves calmness and mindfulness and increases an individual’s awareness and self-control [52]. Hatha yoga (a variation in which only yoga postures are practiced, with little or no meditation) improves HPA axis dysregulation, corrects autonomic balance, and enhances homeostasis by hastening recovery from stress [66]. In a study among 131 participants with mild to moderate stress levels, 10 weeks of a Hatha yoga intervention resulted in significant decreases in stress and anxiety, along with enhanced relaxation [70]. In another study, 90-minute Hatha yoga sessions led to a significant reduction in titers, negative affect, and cortisol levels [2, 72].

Fig. 2
figure 2

Yoga helps to improve various health parameters related to immunity. [Contribution by Mohammad A. Salem, MD; used with written permission]

Yoga helps to reduce the allostatic load of the stress response [73]. It reduces sympathetic overactivity and improves parasympathetic tone during a stressful situation, as indicated by oxygen consumption level, heart rate, and the high-frequency component of heart rate variability [69].

In a meta-analysis by Cramer et al., yoga was found to be an effective intervention for improving depression [68]. Multiple studies have confirmed that yoga practice reduced depression and improved mood and cognitive function among patients with mild to moderate depression. This is achieved by enhancing the HPA axis function, increasing brain-derived neurotrophic factor (BDNF) levels and serotonin levels, and decreasing cortisol and inflammatory markers [68, 74, 75]. Autonomic dysfunction is a hallmark of both anxiety and depression [76]; regular yoga practice of pranayama can help improve autonomic balance by decreasing sympathetic overactivity and improving parasympathetic activity [69]. Yoga also enhances the γ-aminobutyric acid system, which is implicated in anxiety and depression [69].

Yoga also improves various cognitive facets, such as attention, concentration, memory, and executive functioning [71]. By improving body awareness, feelings, and thoughts, yoga facilitates the experience of body sensations in a nonjudgmental way [77]. It also enables the practitioner to focus on present experience instead of ruminating over future or past worries [78]. Self-awareness aids in avoiding addictive or overindulgent behaviors, including overeating and excess sleeping. Yoga helps people remain active and fosters a positive attitude during a lockdown.

Cardio-respiratory protective effects of yoga

Given the severe cardiorespiratory illness manifested in COVID-19 [1], consistent training in yoga may play a protective role. Yoga has numerous positive effects on the cardiovascular and respiratory systems. It has been proven to improve various forms of cardiac arrhythmia, congestive cardiac failure, ischemic heart disease, and hypertension [79,80,81,82,83]. Regular yoga practice attenuates systolic and diastolic blood pressure and mean arterial pressure; it has also been credited with maintaining appropriate blood pressure with less medication [84]. Simply lying down in the Savasana yogic posture for 20 minutes daily was found to be effective in reducing systolic and diastolic blood pressure and the need for antihypertensive medication [85]. Yoga has been shown to improve cardiac function in patients with congestive cardiac failure [86] and to improve baroreflex sensitivity, peripheral vascular resistance, and heart rate variability [87]. It also helps to attenuate catecholamine secretion, which has been implicated in the etiology of severe cardiomyopathy and heart failure [88]. In one study, 8 weeks of yoga intervention led to significant decrease in IL-6, C-reactive protein, and extracellular superoxide dismutase, compared with non-yoga controls in patients with heart failure [89]. Thus, evidence indicates that yoga offers multi-faceted protection from cardiac damage mitigated by aberrant cytokine release, such as that seen with COVID-19.


Our review is up-to-date, and the findings are of significant relevance but the important limitations must be considered. The literature was searched and summarized thoroughly but our review was not systematic, thus increasing the possibilities of selection and publication bias. Our study included only articles in English thus introducing a language bias. The associations and characteristics identified in this review await clearly proven causative mechanisms. Important confounders exist in the cross-sectional studies reviewed in the form of age, medications, and immune strength. Larger randomized controlled trials will provide necessary insight on the role of yoga in immunomodulation and mental health during the present pandemic.


The aggregation of pathophysiological aberrations, both psychological and somatic, secondary to COVID-19 pandemic and its resultant restrictions, may increase the severity of the infection. Accumulated evidence leads us to hypothesize that, for many, yoga practice may attenuate the ill effects of COVID-19–induced immune dysfunction at different stages.

From a public health perspective, yoga represents a low-cost, noninvasive strategy for alleviating the physical and emotional toll of the COVID-19 pandemic. The aforementioned yoga practices can be performed at home, in adherence to social distancing guidelines. Outcomes from an 8-week yoga intervention (asanas, pranayama, and meditation) indicated that medical treatment plus yoga is more effective than medical treatment alone in reducing anxiety [90]. Relaxation techniques like yoga and meditation helps in managing chronic or long term stress by regulating the cytokines, thus assisting people to overcome co-morbidities associated with diseases and improving the quality of life; which is important in COVID-19 and post-COVID illness [2, 21]. Notwithstanding, appropriate clinical trials are required to document the efficacy of this strategy.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.



Angiotensin-converting enzyme


Brain-derived neurotrophic factor


Coronavirus disease


Cytokine release syndrome


Human immunodeficiency virus






Immunoglobulin A




Tumor necrosis factor


  1. Basu-Ray I, Almaddah N, Adeboye A, Soos MP. Cardiac manifestations of coronavirus (COVID-19). In: StatPearls. Treasure Island FL: StatPearls Publishing LLC; 2020.

    Google Scholar 

  2. Basu-Ray I, Metri K. Yoga as a potential intervention for preventing cardiac complications in COVID-19: augmenting immuno-modulation and bolstering mental health in the the principles and practice of yoga in cardiovascular medicine. Rd: Basu-Ray I & Mehta D Springer Nature, Chapter:29. 2022.

  3. Basu-Ray I. Yoga In Covid-19 Pandemic: Protective Envelope or Mere Ritual?. Science India. 2021.

  4. Weiss SR, Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev. 2005;69:635–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. World Health Organization. Coronavirus disease (COVID-2019) situation reports. (2020). Available online at: (Accessed Jun 30, 2020).

    Google Scholar 

  6. Elson BD, Hauri P, Cunis D. Physiological changes in yoga meditation. Psychophysiology. 1977;14:52–7.

    Article  CAS  PubMed  Google Scholar 

  7. Innes KE, Selfe TK. Yoga for adults with type 2 diabetes: a systematic review of controlled trials. J Diabetes Res. 2016;2016:6979370.

    Article  Google Scholar 

  8. Desveaux L, Lee A, Goldstein R, Brooks D. Yoga in the management of chronic disease: a systematic review and meta-analysis. Med Care. 2015;53:653–61.

    Article  PubMed  Google Scholar 

  9. Prinster T. Yoga for Cancer: a guide to managing side effects, boosting immunity, and improving recovery for Cancer survivors. Rochester VT: Healing Arts Press; 2014. p. 324.

    Google Scholar 

  10. Harinath K, Malhotra AS, Pal K, Prasad R, Kumar R, Kain TC, et al. Effects of hatha yoga and Omkar meditation on cardiorespiratory performance, psychologic profile, and melatonin secretion. J Altern Complement Med. 2004;10:261–8.

    Article  PubMed  Google Scholar 

  11. Hagen I, Nayar US. Yoga for children and young people's mental health and well-being: research review and reflections on the mental health potentials of yoga. Front Psychiatry. 2014;5:35.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020.

  17. Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184(4):861–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20:269–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. CDC Covid-Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) - United States, February 12-march 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:343–6.

    Article  Google Scholar 

  21. Arora S, Bhattacharjee J. Modulation of immune responses in stress by yoga. Int J Yoga. 2008;1:45–55.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39:529–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395:1569–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Pappa S, Ntella V, Giannakas T, Giannakoulis VG, Papoutsi E, Katsaounou P. Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis. Brain Behav Immun. 2020.

  25. Godinić D, Obrenovic B, Khudaykulov A. Effects of economic uncertainty on mental health in the COVID-19 pandemic context: social identity disturbance, job uncertainty and psychological well-being model. Int J Innov Econ Dev. 2020;6:61–74.

    Article  Google Scholar 

  26. Ackerman KD, Martino M, Heyman R, Moyna NM, Rabin BS. Immunologic response to acute psychological stress in MS patients and controls. J Neuroimmunol. 1996;68:85–94.

    Article  CAS  PubMed  Google Scholar 

  27. Locke S, Hurst M, Heisel J, Kraus L, Williams M. The influence of stress and other psychosocial factors on human immunity. Paper presented at the 36th Annual Meeting of the Psychosomatic Society, Dallas TX. 1979.

  28. Vedhara K, Cox NK, Wilcock GK, Perks P, Hunt M, Anderson S, et al. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet. 1999;353:627–31.

    Article  CAS  PubMed  Google Scholar 

  29. Lambert EA, Lambert GW. Stress and its role in sympathetic nervous system activation in hypertension and the metabolic syndrome. Curr Hypertens Rep. 2011;13:244–8.

    Article  PubMed  Google Scholar 

  30. Van Westerloo DJ, Choi G, Löwenberg EC, Truijen J, de Vos AF, Endert E, et al. Acute stress elicited by bungee jumping suppresses human innate immunity. Mol Med. 2011;17:180–8.

    Article  CAS  PubMed  Google Scholar 

  31. Joseph JJ, Golden SH. Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Ann N Y Acad Sci. 2017;1391:20–34.

    Article  PubMed  Google Scholar 

  32. Pedersen A, Zachariae R, Bovbjerg DH. Influence of psychological stress on upper respiratory infection--a meta-analysis of prospective studies. Psychosom Med. 2010;72:823–32.

    Article  PubMed  Google Scholar 

  33. Vedhara K, McDermott MP, Evans TG, Treanor JJ, Plummer S, Tallon D, et al. Chronic stress in nonelderly caregivers: psychological, endocrine and immune implications. J Psychosom Res. 2002;53:1153–61.

    Article  PubMed  Google Scholar 

  34. Miller GE, Cohen S, Ritchey AK. Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol. 2002;21:531–41.

    Article  PubMed  Google Scholar 

  35. Miller GE, Chen E, Fok AK, Walker H, Lim A, Nicholls EF, et al. Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc Natl Acad Sci U S A. 2009;106:14716–21.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25:1822–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Wang Q, Xu R, Volkow ND. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States.

  38. Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014;140(3):774–815.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Targum SD, Sullivan AC, Byrnes SM. Neuroendocrine interrelationships in major depressive disorder. Am J Psychiatry. 1982;139:282–6.

    Article  CAS  PubMed  Google Scholar 

  40. Olff M. Stress, depression and immunity: the role of defense and coping styles. Psychiatry Res. 1999;85:7–15.

    Article  CAS  PubMed  Google Scholar 

  41. Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between covid-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8(2):130–40.

    Article  PubMed  Google Scholar 

  42. Agnihotri S, Kant S, Kumar S, Mishra RK, Mishra SK. Impact of yoga on biochemical profile of asthmatics: a randomized controlled study. Int J Yoga. 2014;7:17–21.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Koh KB, Lee Y. Reduced anxiety level by therapeutic interventions and cell-mediated immunity in panic disorder patients. Psychother Psychosom. 2004;73:286–92.

    Article  PubMed  Google Scholar 

  44. Nagata T, Yamada H, Iketani T, Kiriike N. Relationship between plasma concentrations of cytokines, ratio of CD4 and CD8, lymphocyte proliferative responses, and depressive and anxiety state in bulimia nervosa. J Psychosom Res. 2006;60:99–103.

    Article  PubMed  Google Scholar 

  45. Michopoulos V, Powers A, Gillespie CF, Ressler KJ, Jovanovic T. Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology. 2017;42:254–70.

    Article  CAS  PubMed  Google Scholar 

  46. Atanackovic D, Kröger H, Serke S, Deter HC. Immune parameters in patients with anxiety or depression during psychotherapy. J Affect Disord. 2004;81:201–9.

    Article  CAS  PubMed  Google Scholar 

  47. Naoroibam R, Metri KG, Bhargav H, Nagaratna R, Nagendra HR. Effect of integrated yoga (IY) on psychological states and CD4 counts of HIV-1 infected patients: a randomized controlled pilot study. Int J Yoga. 2016;9:57–61.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Gopal A, Mondal S, Gandhi A, Arora S, Bhattacharjee J. Effect of integrated yoga practices on immune responses in examination stress - a preliminary study. Int J Yoga. 2011;4:26–32.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Hari Chandra BP, Ramesh MN, Nagendra HR. Effect of yoga on immune parameters, cognitive functions, and quality of life among HIV-positive children/adolescents: a pilot study. Int J Yoga. 2019;12:132–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Vijayaraghava A, Doreswamy V, Narasipur OS, Kunnavil R, Srinivasamurthy N. Effect of yoga practice on levels of inflammatory markers after moderate and strenuous exercise. J Clin Diagn Res. 2015;9:CC08–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Rao RM, Nagendra HR, Raghuram N, Vinay C, Chandrashekara S, Gopinath KS, et al. Influence of yoga on mood states, distress, quality of life and immune outcomes in early stage breast cancer patients undergoing surgery. Int J Yoga. 2008;1:11–20.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Cook-Cottone CP. Mindfulness and yoga for self-regulation: a primer for mental health professionals. New York: Springer Publishing Company; 2015. p. 322.

    Book  Google Scholar 

  53. Chen PJ, Yang L, Chou CC, Li CC, Chang YC, Liaw JJ. Effects of prenatal yoga on women’s stress and immune function across pregnancy: a randomized controlled trial. Complement Ther Med. 2017;31:109–17.

    Article  PubMed  Google Scholar 

  54. Bradley PA, Bourne FJ, Brown PJ. The respiratory tract immune system in the pig. I. Distribution of immunoglobulin-containing cells in the respiratory tract mucosa. Vet Pathol. 1976;13:81–9.

    Article  CAS  PubMed  Google Scholar 

  55. Yadav RK, Magan D, Mehta N, Sharma R, Mahapatra SC. Efficacy of a short-term yoga-based lifestyle intervention in reducing stress and inflammation: preliminary results. J Altern Complement Med. 2012;18:662–7.

    Article  PubMed  Google Scholar 

  56. Kiloor A, Kumari S, Metri K. Impact of yoga on psychopathologies and QoLin persons with HIV: a randomized controlled study. J Bodyw Mov Ther. 2019;23:P278–83.

    Article  Google Scholar 

  57. Musher DM, Abers MS, Corrales-Medina VF. Acute infection and myocardial infarction. N Engl J Med. 2019;380:171–6.

    Article  CAS  PubMed  Google Scholar 

  58. Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020;55:105954.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. Tocilizumab treatment in COVID-19: a single center experience. J Med Virol. 2020;92:814–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Nagarathna R, Nagendra H, Majumdar V. A perspective on yoga as a preventive strategy for coronavirus disease 2019. Int J Yoga. 2020;13:89–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Pullen PR, Thompson WR, Benardot D, Brandon LJ, Mehta PK, Rifai L, et al. Benefits of yoga for African American heart failure patients. Med Sci Sports Exerc. 2010;42:651–7.

    Article  PubMed  Google Scholar 

  62. Chen N, Xia X, Qin L, Luo L, Han S, Wang G, et al. Effects of 8-week hatha yoga training on metabolic and inflammatory markers in healthy, female Chinese subjects: a randomized clinical trial. Biomed Res Int. 2016;2016:5387258.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Kiecolt-Glaser JK, Bennett JM, Andridge R, Peng J, Shapiro CL, Malarkey WB, et al. Yoga’s impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2014;32:1040–9.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Rajbhoj PH, Shete SU, Verma A, Bhogal RS. Effect of yoga module on pro-inflammatory and anti-inflammatory cytokines in industrial workers of Lonavla: a randomized controlled trial. J Clin Diagn Res. 2015;9:CC01–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Michalsen A, Grossman P, Acil A, Langhorst J, Lüdtke R, Esch T, et al. Rapid stress reduction and anxiolysis among distressed women as a consequence of a three-month intensive yoga program. Med Sci Monit. 2005;11:CR555–61.

    PubMed  Google Scholar 

  66. Patil SG, Aithala MR, Naregal GV, Shanmukhe AG, Chopade SS. Effect of yoga on cardiac autonomic dysfunction and insulin resistance in non-diabetic offspring of type-2-diabetes parents: a randomized controlled study. Complement Ther Clin Pract. 2019;34:288–93.

    Article  PubMed  Google Scholar 

  67. Bower JE, Greendale G, Crosswell AD, Garet D, Sternlieb B, Ganz PA, et al. Yoga reduces inflammatory signaling in fatigued breast cancer survivors: a randomized controlled trial. Psychoneuroendocrinology. 2014;43:20–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Cramer H, Lauche R, Langhorst J, Dobos G. Yoga for depression: a systematic review and meta-analysis. Depress Anxiety. 2013;30:1068–83.

    Article  PubMed  Google Scholar 

  69. Vempati RP, Telles S. Yoga-based guided relaxation reduces sympathetic activity judged from baseline levels. Psychol Rep. 2002;90:487–94.

    Article  CAS  PubMed  Google Scholar 

  70. Smith C, Hancock H, Blake-Mortimer J, Eckert K. A randomised comparative trial of yoga and relaxation to reduce stress and anxiety. Complement Ther Med. 2007;15:77–83.

    Article  PubMed  Google Scholar 

  71. Luu K, Hall PA. Hatha yoga and executive function: a systematic review. J Altern Complement Med. 2016;22:125–33.

    Article  PubMed  Google Scholar 

  72. West J, Otte C, Geher K, Johnson J, Mohr DC. Effects of hatha yoga and African dance on perceived stress, affect, and salivary cortisol. Ann Behav Med. 2004;28:114–8.

    Article  PubMed  Google Scholar 

  73. Streeter CC, Gerbarg PL, Saper RB, Ciraulo DA, Brown RP. Effects of yoga on the autonomic nervous system, gamma-aminobutyric-acid, and allostasis in epilepsy, depression, and post-traumatic stress disorder. Med Hypotheses. 2012;78:571–9.

    Article  CAS  PubMed  Google Scholar 

  74. Naveen GH, Varambally S, Thirthalli J, Rao M, Christopher R, Gangadhar BN. Serum cortisol and BDNF in patients with major depression--effect of yoga. Int Rev Psychiatry. 2016;28:273–8.

    Article  CAS  PubMed  Google Scholar 

  75. Janakiramaiah N, Gangadhar BN, Naga Venkatesha Murthy PJ, Harish MG, Subbakrishna DK, Vedamurthachar A. Antidepressant efficacy of Sudarshan Kriya yoga (SKY) in melancholia: a randomized comparison with electroconvulsive therapy (ECT) and imipramine. J Affect Disord. 2000;57:255–9.

    Article  CAS  PubMed  Google Scholar 

  76. Sarubin N, Nothdurfter C, Schüle C, Lieb M, Uhr M, Born C, et al. The influence of hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: a randomized trial. J Psychiatr Res. 2014;53:76–83.

    Article  PubMed  Google Scholar 

  77. Daubenmier JJ. The relationship of yoga, body awareness, and body responsiveness to self-objectification and disordered eating. Psychol Women Q. 2005;29:207–19.

    Article  Google Scholar 

  78. Shelov DV, Suchday S, Friedberg JP. A pilot study measuring the impact of yoga on the trait of mindfulness. Behav Cogn Psychother. 2009;37:595–8.

    Article  PubMed  Google Scholar 

  79. Posadzki P, Cramer H, Kuzdzal A, Lee MS, Ernst E. Yoga for hypertension: a systematic review of randomized clinical trials. Complement Ther Med. 2014;22:511–22.

    Article  PubMed  Google Scholar 

  80. Bhavanani AB, Ramanathan M, Balaji R, Pushpa D. Comparative immediate effect of different yoga asanas on heart rate and blood pressure in healthy young volunteers. Int J Yoga. 2014;7:89–95.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Lakkireddy D, Atkins D, Pillarisetti J, Ryschon K, Bommana S, Drisko J, et al. Effect of yoga on arrhythmia burden, anxiety, depression, and quality of life in paroxysmal atrial fibrillation: the YOGA my heart study. J Am Coll Cardiol. 2013;61:1177–82.

    Article  PubMed  Google Scholar 

  82. Hagins M, States R, Selfe T, Innes K. Effectiveness of yoga for hypertension: systematic review and meta-analysis. Evid Based Complement Alternat Med. 2013;2013:649836.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Patel C, North WR. Randomised controlled trial of yoga and bio-feedback in management of hypertension. Lancet. 1975;2:93–5.

    Article  CAS  PubMed  Google Scholar 

  84. Veerabhadrappa SG, Baljoshi VS, Khanapure S, Herur A, Patil S, Ankad RB, et al. Effect of yogic bellows on cardiovascular autonomic reactivity. J Cardiovasc Dis Res. 2011;2:223–7.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Santaella DF, Lorenzi-Filho G, Rodrigues MR, Tinucci T, Malinauskas AP, Mion-Júnior D, et al. Yoga relaxation (savasana) decreases cardiac sympathovagal balance in hypertensive patients. MedicalExpress. 2014;1:233–8.

    Google Scholar 

  86. Krishna BH, Pal P, Pal GK, Balachander J, Jayasettiaseelon E, Sreekanth Y, et al. Effect of yoga therapy on heart rate, blood pressure and cardiac autonomic function in heart failure. J Clin Diagn Res. 2014;8:14–6.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Bowman AJ, Clayton RH, Murray A, Reed JW, Subhan MM, Ford GA. Effects of aerobic exercise training and yoga on the baroreflex in healthy elderly persons. Eur J Clin Investig. 1997;27:443–9.

    Article  CAS  Google Scholar 

  88. Rajak C, Verma R, Singh P, Singh A, Shiralkar M. Effect of yoga on serum adrenaline, serum cortisol levels and cardiovascular parameters in hyper-reactors to cold pressor test in young healthy volunteers. Eur J of Pharm Med Res. 2016;3:496–502.

    Google Scholar 

  89. Pullen PR, Nagamia SH, Mehta PK, Thompson WR, Benardot D, Hammoud R, et al. Effects of yoga on inflammation and exercise capacity in patients with chronic heart failure. J Card Fail. 2008;14:407–13.

    Article  PubMed  Google Scholar 

  90. Sharma P, Poojary G, Dwivedi SN, Deepak KK. Effect of yoga-based intervention in patients with inflammatory bowel disease. Int J Yoga Therap. 2015;25:101–12.

    Article  PubMed  Google Scholar 

Download references


Jeanie F. Woodruff, BS, ELS, contributed to the editing of this manuscript.



Author information

Authors and Affiliations



IBR: Hypothesis and concept, KM, DK, RR, KC: Research and Manuscript preparation: KC, AA, IBR, KM, DK, RR, KC, NR, MCM, BP, MS, IVB, AA, SR, DKK, ML, ST, GNL, HC, GF, and NRH: Manuscript review and contribution of critical intellectual content, including figures and tables. The author(s) read approved the final manuscript.

Corresponding author

Correspondence to Indranill Basu-Ray.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Basu-Ray, I., Metri, K., Khanra, D. et al. A narrative review on yoga: a potential intervention for augmenting immunomodulation and mental health in COVID-19. BMC Complement Med Ther 22, 191 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: